WebEarlyTect® Colorectal Cancer Test is a molecular diagnostic test that uses the in vitro detection medical device of EarlyTect Colon Cancer (KFDA Approval No. 18-593) to quantify the methylation of syndecan-2(SCD2) DNA extracted from human stools through a real-time PCR to supplementarily detect colorectal cancer. http://m.yakup.com/news/index.html?mode=view&pmode=&cat=all&cat2=&cat3=&nid=232425&num_start=47248
The best treatment is to discover colorectal cancer early. - Earlytect
WebJun 28, 2024 · The EarlyTect ® Colorectal Cancer Assay The EarlyTect ® CRC test (Genomictree Inc. Daejeon, South Korea) has recently received CE-IVD certification for the diagnosis of CRC. The EarlyTect ™ -GI Syndecan2 Methylation Assay is an IVD assay that uses cfDNA isolated from 0.5 ml of serum to analyze the methylation status of SDC2 … WebEarlyTect® Colorectal Cancer Test is a molecular diagnostic test that uses the in vitro detection medical device of EarlyTect Colon Cancer (KFDA Approval No. 18-593) to quantify the methylation of syndecan-2(SCD2) DNA extracted from human stools … simple machines make work easier but not
지노믹트리(228760) 소폭 상승세 +4.39%
Web‘건강 검진’ 목적 사용...‘병원 처방’ 영역까지 시장 확대 지노믹트리(대표 안성환)는 대장암 보조진단 검사 ‘얼리텍-c®’가 ‘한국보건의료연구원’으로부터 신의료기술평가 유예 대상으로 확정됐다고 13일 밝혔다. ‘얼리텍-c®’ 대장암검사는 지노믹트리가 발굴하고 독창적으로 개발한 ... WebCologuard. Cologuard is a screening test for colon and rectal cancer. The colon sheds cells from its lining every day. These cells pass with the stool through the colon. The cancer cells may have DNA changes in certain genes. Cologuard detects the altered DNA. WebEarlyTect Colon Cancer Test is a qualitative real-time PCR test that measures methylated Syndecan-2, a biomarker clinically related to precancerous lesions of CRC, in stool DNA to diagnose colorectal cancer. This product is not intended to confirm colorectal cancer, so if a subject was positive, CRC or precancerous lesions of CRC may exist. rawstarr records